IL6 and metabolic dysfunction-associated steatohepatitis: IL-6 levels are elevated in the serum and adipocytes of obese patients, and the level of expression is significantly higher in adipose tissue than in liver, suggesting that adipose tissue is the main source of IL-6 in NASH [96, 97].